Current use of tibolone was also associated with elevated odds ratios that did not reach statistical significance, and that increased with duration of use (p trend=0.07).
← all excerpts
Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
1
—
—